This invention relates to selenophene compounds of formula (I) shown below:
Each variable in formula (I) is defined in the specification. These compounds can be used to treat cancer.
[EN] PROTEIN KINASE INHIBITORS<br/>[FR] INHIBITEURS DES PROTÉINES KINASES
申请人:DCB USA LLC
公开号:WO2009085040A1
公开(公告)日:2009-07-09
This invention relates to selenophene compounds of formula (I) shown below; each variable in formula (I) is defined in the specification. These compounds can be used to treat cancer.
A series of selenophene derivatives 3 were synthesized as potential CHK1 inhibitors. The effects of substitution on the 4'- or 5'-position of selenophene moiety and shifting the hydroxyl group position on C6-phenolic ring of oxindole were explored. This study led to the discovery of the most potent CHK1 inhibitors 29-33 and 39-43, which had IC(50) values in the subnanomolar range. (C) 2010 Elsevier Ltd. All rights reserved.
Shulezhko,A.A., Journal of Organic Chemistry USSR (English Translation), 1970, vol. 6, p. 2129 - 2132
作者:Shulezhko,A.A.
DOI:——
日期:——
ELCHANINOV, M. M.;SIMONOV, A. M.;MAGDESIEVA, N. N.;KAMINSKIJ, A. YA., XIMIYA GETEROTSIKL. SOED.,(1987) N 12, 1636-1639
作者:ELCHANINOV, M. M.、SIMONOV, A. M.、MAGDESIEVA, N. N.、KAMINSKIJ, A. YA.